Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	17.65B
Revenue (ttm)	12.02B
Net Income (ttm)	1.03B
Shares Out	1.16B
EPS (ttm)	0.89
PE Ratio	17.19
Forward PE	15.43
Dividend	0.36 (2.34%)
Ex-Dividend Date	May 23, 2024

Volume	10,381,652
Average Volume	15,883,618
Open	15.18
Previous Close	15.33
Day's Range	15.18 - 15.47
52-Week Range	12.32 - 18.96
Beta	0.14
RSI	42.50
Earnings Date	Mar 11, 2025

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,060
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.